Press release
Smoking Cessation and Nicotine De-addiction Products Market Revenue Opportunies, Rising at a CAGR of 17.3% and Top players Johnson & Johnson Limited, GlaxoSmithKline plc, Novartis International AG, Pfizer, Inc., and Cipla Ltd., Takeda Pharmaceuticals Co.
Cigarette packs have been mandatorily carrying a warning stating ‘Smoking is injurious to Health’, while some countries have resorted to even more graphic visuals of victims of smoking. However, this has done precious little to encourage smoking cessation. It is only through awareness created by NGOs and global healthcare organizations that we observe initiatives to stop smoking among the smoking population. Moreover, focus on introducing therapies for smoking cessation has led to development of various alternative therapies in the global smoking cessation and nicotine de-addiction products market. Nicotex, Nicogum, Smokefree, and KwikNic are some of the major nicotine replacement therapy (NRT) brands available in the smoking cessation and nicotine de-addiction products market. Nicotine addiction is in fact a major contributing factor for higher sales of cigarettes. Therefore, nicotine de-addiction products such as nicotine gums and patches are commercialized in the market.Nicotine replacement therapies (NRTs) were the first FDA approved products for smoking cessation treatment. Besides, Buproprion (Zyban) and Varenicline (Chantix) are the two non-nicotine FDA approved products intended for smoking cessation. Electronic nicotine delivery systems (ENDS) are other emerging products aiding in nicotine de-addiction. E-cigarettes can be nicotine-based on non-nicotine based.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/134
E-cigarettes: An emerging segment in the smoking cessation and nicotine de-addiction products market
E-cigarette is an electronic nicotine delivery system (ENDS) that is regulated by FDA. E-cigarettes are effective in reducing tobacco related health conditions, while NRTs work best for smoking cessation. E-cigarettes are a potential threat to tobacco based cigarettes, at the same time an opportunity for tobacco manufacturers to enter the new emerging segment catering to the smoking population. Companies such as BAT, Lorillard, Japan Tobacco International, and Philip Morris International (PMI) collaborated with/acquired smaller firms who developed e-cigarettes. This provides major companies in the cigarettes market to compensate for their on-going downward sales of cigarettes. This would give a major boost to the overall smoking cessation and nicotine de-addiction products market. Furthermore, the consideration that e-cigarettes are less harmful than regular cigarettes, no smoke and thus no risk of passive smoking, allowed to use even in no-smoking places, varying nicotine levels and availability in various flavors are some of the major driving factors for e-cigarettes market.
High smoking rates and nicotine addiction
According to the World Health Organization (WHO), tobacco results in one premature death every six seconds globally. Moreover, in 2015, over 1.1 billion people smoked tobacco globally, with the rate increasing in Africa and Mediterranean Region. Also, tobacco smoking prevalence is the highest in Asia. Therefore, this could be a potential market for the manufacturers in the global smoking cessation and nicotine de-addiction products market. Nicotine being a major addictive component, is harmful to active and passive smokers. Furthermore, concerns regarding the uptake of e-cigarettes by non-smokers considering it as safe for smoking is deterring growth of e-cigarettes in unregulated markets such as India.
Creating awareness about health impacts related to smoking to aid the growth of smoking cessation and nicotine de-addiction products market
Around 7 out of 10 of smokers in the U.S. reported the desire to quit smoking in 2015, as per results of a study by the Centers for Disease Control and Prevention (CDC). However, lack of motivation, support, and also proper therapy guidance is hindering uptake of smoking cessation and nicotine de-addiction products. Furthermore, use of e-cigarettes in unregulated markets such as India and Africa is under surveillance by regulatory authorities. The WHO has expressed concern over the sale of e-cigarettes in India openly through online marketplace and has advised companies to include health warnings when marketing the product, unless substantial evidences confirming its safety are found.
Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/134
smoking cessation and nicotine de-addiction products Market Taxonomy:
Global Smoking Cessation and Nicotine De-addiction Products Market, By Product Type:
Nicotine Replacement Therapy
OTC
Nicotine Spray
Nicotine Inhalers
Nicotine Gum
Nicotine Transdermal Patches
Prescription
Nicotine Sublingual Tablets
Nicotine Lozenges
Drugs
Varenicline
Zyban
E-Cigarettes
Modular
Disposable
Rechargeable
Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel:
Hospital Pharmacies
Online Channel
Retail Pharmacies
Others
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
#3200
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Smoking Cessation and Nicotine De-addiction Products Market Revenue Opportunies, Rising at a CAGR of 17.3% and Top players Johnson & Johnson Limited, GlaxoSmithKline plc, Novartis International AG, Pfizer, Inc., and Cipla Ltd., Takeda Pharmaceuticals Co. here
News-ID: 1297559 • Views: …
More Releases from CMI Market Research - Pharmaceutical Industry

Regenerative Medicine Market growth and trends by 2018-2025 | Depuy Synthes, Inc …
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases,…

Precision Medicine Market Revenue Opportunies, Rising at a CAGR of 9.9% and Lead …
Precision medicine is an emerging field, which tailors the treatment according to the individual’s genetic makeup, lifestyle, and environment. The precision medicine have gained popularity due to the positive result obtained by precision medicine in treatment of cancer. It allows the doctors and researchers to predict more accurate treatment and preventive strategies for any particular disease. Precision medicine has also challenged the approach of one drug fits all, as every…

Regenerative Medicine Market Demand Analysis of Application, Types, Users by Key …
Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases,…

Antifungal Drugs Market Industry Analysis, Trends and Growth Opportunities Forec …
As the name suggests, anti-fungal drugs are used to treat fungal infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Fungal infection is usually associated with a weak immune system, with people suffering from HIV and…
More Releases for Nicotine
Oral Nicotine Products Market Is Booming So Rapidly | Major Giants Nicotine Pouc …
HTF MI recently introduced Global Oral Nicotine Products Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Oral Nicotine Products Market are: Swedish Match (Sweden), Altria (USA), British American Tobacco (UK), Philip Morris International (USA/Switzerland),…
Nicotine and Nicotine Salts Market | Exploring Current Trends and Growth Status …
Nicotine and Nicotine Salts Market Outlook and Investment Analysis
What is the current outlook of the Nicotine and Nicotine Salts market?
The Nicotine and Nicotine Salts market is experiencing rapid growth driven by rising consumer demand for e-cigarettes and other nicotine delivery systems. Increasing awareness about smoking cessation products, along with the shift towards less harmful alternatives like vaping, has contributed to the market's expansion. The rising trend of e-cigarette usage, particularly…
Nicotine Gum Market: A Comprehensive Overview
The Global Nicotine Gum Market was valued at approximately USD 1.63 billion in 2023 and is projected to reach around USD 2.55 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2032.
Nicotine Gum Market Overview
The nicotine gum market is experiencing steady growth, primarily driven by increasing health awareness and the rising prevalence of smoking-related illnesses. As more individuals seek effective smoking cessation…
Sofi Surge Zero Nicotine: A Revolutionary Leap in Nicotine-Free Vaping
[Tustin, 09.12.2024] - The vaping industry is transformed once again with the introduction of the Sofi Surge Zero Nicotine, a cutting-edge disposable device designed for those seeking a nicotine-free vaping experience. This innovative product is poised to make waves among vapers who desire the pleasure of vaping without the addictive component of nicotine, while still enjoying unmatched flavor and convenience.
With a remarkable 25,000 puff capacity, the Sofi Surge Zero Nicotine…
Global Nicotine Market Research Report
This report studies the global Nicotine market status and forecast, categorizes the global Nicotine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Alchem International Siegfried CAMBREX CHARLES CITY FERTIN PHARMA JOHNSON AND JOHNSON CONSUMER INC Laboratorios Haymann Mallinckrodt Pharmaceuticals PORTON FINE…
Global Nicotine Polacrilex Market Research Report
This report studies the global Nicotine Polacrilex market status and forecast, categorizes the global Nicotine Polacrilex market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report BGP HEALTHCARE Cambrex Corporate Nicobrand Alchem International DIXIE CHEMICAL FERTIN PHARMA Laboratorios Haymann MALLINCKRODT NICOBRAND PORTON FINE…